In summary, the results presented here and summarized in Figure 9 show that, by downregulating VDAC1 in GBM and lung and breast cancer, we re-programmed cell energy, metabolism, and other cell functions essential for cancer cell survival. This evidence concerns the gene VDAC1 and glioblastoma.